Bill · H.R. 8630· House(119-HR-8630)

PEAT Act of 2026

Age: 57 years

Ohio

Introduced: 4/30/2026
Last activity: 4/30/2026 — Referred to the House Committee on Energy and Commerce.
Sponsored by: Michael Rulli
Cosponsors: - 11 - 1

Health

Introduced
In Committee

What this bill would do

This bill, known as the "Protecting Equal Access to Thyroid Act of 2026" or the "PEAT Act of 2026," seeks to amend the Public Health Service Act. It specifically targets how biologics are classified. The bill proposes a prohibition on treating a biologic as a biological product based only on the presence of a protein that is a clinically inactive component. This change would alter the existing definitions within the Public Health Service Act.

Yes· 3 of 4

Does this lower the price of prescription medicines?+4
By preventing certain proteins from disqualifying products from being classified as biologics, the bill may facilitate the entry of more cost-effective treatments into the market.
Does this make health care easier to get in general?+3
The bill's reclassification of biologics could potentially lower barriers to accessing specific types of therapeutic products.
Would households on low incomes be better off under this?+2
Changes in biologic classification may eventually lead to lower costs for essential medications used by low-income populations.